Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer
Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), is employed for treatment of several cancers and retinopathies. Although previous reports of remission of psoriasis with bevacizumab do exist, but its current experience for psoriatic arthritis (PsA) is still limit...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wolters Kluwer Medknow Publications
2014-01-01
|
| Edice: | Indian Journal of Dermatology |
| Témata: | |
| On-line přístup: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2014;volume=59;issue=6;spage=632;epage=632;aulast=Datta-Mitra |